MASS 908 Devices Inc. logo

MASS 908 Devices Inc.

Healthcare
$7.81+0.00%OpenMarket Cap: $295.3M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

12.96

PEG

0.10

P/B

2.00

P/S

4.76

EV/EBITDA

-11.03

DCF Value

$-9.52

FCF Yield

-3.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

49.0%

Operating Margin

-52.5%

Net Margin

-62.1%

ROE

-25.5%

ROA

-19.2%

ROIC

-20.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$13.4M$-12.0M$
Q4 null$17.4M$4.3M$
FY null$56.2M$-36.6M$
Q3 null$14.0M$-14.9M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Leerink PartnersOutperform
2025-08-05

Trading Activity

Insider Trades

View All
AWM Investment Company, Inc.10 percent owner
SellWed May 13
Kenneweg Johnofficer: SVP, Sales & Product Marketing
SellMon May 11
AWM Investment Company, Inc.10 percent owner
SellFri May 08
AWM Investment Company, Inc.10 percent owner
SellFri May 08
AWM Investment Company, Inc.10 percent owner
SellFri May 08

Company Info

Sector

Healthcare

Industry

Medical - Devices

Country

US

Exchange

Beta

0.56

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Peers